Wan-jun Cheng Selected Research

Hypertension (High Blood Pressure)

1/2009	[Effects of upstream tirofiban versus downstream tirofiban on platelet aggregation and clinical outcomes in patients with high-risk acute coronary syndromes undergoing percutaneous coronary interventions].
5/2008	Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wan-jun Cheng Research Topics

Disease

2	Acute Coronary Syndrome 01/2009 - 05/2008
2	Hypertension (High Blood Pressure) 01/2009 - 05/2008
2	Myocardial Infarction 05/2008 - 07/2006
1	Hemorrhage 01/2009
1	Thrombocytopenia (Thrombopenia) 01/2009
1	Pain (Aches) 05/2007
1	Inflammation (Inflammations) 05/2007
1	Prostatitis 05/2007
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2006
1	Type 2 Diabetes Mellitus (MODY) 07/2006

Drug/Important Bio-Agent (IBA)

2	omega-Chloroacetophenone (Mace)IBA 01/2009 - 05/2008
1	Tirofiban (Aggrastat)FDA Link 01/2009
1	CreatinineIBA 05/2008
1	MetalsIBA 05/2008
1	Analgesics (Analgesic Drugs)IBA 05/2007
1	SolutionsIBA 05/2007
1	Xylenes (Xylene)IBA 05/2007
1	Acetic Acid (Vinegar)FDA LinkGeneric 05/2007
1	ThiazolidinedionesIBA 07/2006
1	Rosiglitazone (Avandia)FDA Link 07/2006

Therapy/Procedure

2	Percutaneous Coronary Intervention 01/2009 - 05/2008
2	Stents 05/2008 - 07/2006
1	Drug-Eluting Stents 05/2008